past Attendees at our event

Standard BioTools
Standard BioTools
Tessera Therapeutics
Tessera Therapeutics
TriLink BioTechnologies
TriLink BioTechnologies
University of Michigan
University of Michigan
28 Capital
28 Capital
Arcturus Therapeutics
Arcturus Therapeutics
Crafton Biotechnology
Crafton Biotechnology
DNA Script
DNA Script
Lovelace Biomedical
Lovelace Biomedical
Mayo Clinic
Mayo Clinic
Orna Therapeutics
Orna Therapeutics
Sanofi
Sanofi

Topics On The Agenda

A NEW APPROACH TO PLASMID DNA CHARACTERIZATION FOR IVT WITH SLALOM CHROMATOGRAPHY

Day 1: MONDAY, APRIL 27, 2026

09:10 - 09:35

WHAT 3,000 RNA PROJECTS REVEAL ABOUT ENGINEERING mRNA, saRNA, AND circRNA

Day 1: MONDAY, APRIL 27, 2026

09:40 - 10:05

ENHANCING mRNA–LNP DOWNSTREAM PROCESSING VIA SINGLE-PASS TANGENTIAL FLOW FILTRATION (SPTFF)

Day 1: MONDAY, APRIL 27, 2026

10:10 - 10:35

View more topics

Meet the Leaders

GlaxoSmithKline
GlaxoSmithKline
Johnson & Johnson
Johnson & Johnson
Merck
Merck
Moderna
Moderna
Novartis
Novartis
Otsuka Pharmaceuticals
Otsuka Pharmaceuticals
Pfizer
Pfizer
Sanofi
Sanofi
Abbott Laboratories
Abbott Laboratories
AbbVie
AbbVie
Amgen
Amgen
Arcturus Therapeutics
Arcturus Therapeutics
AstraZenec
AstraZenec
Bayer
Bayer
Bristol-Myers Squibb
Bristol-Myers Squibb
CSL Seqirus
CSL Seqirus
Eli Lilly
Eli Lilly
Evonik
Evonik

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.